NCT07225621 2026-02-05
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
Alpheus Medical, Inc.
Phase 2 Recruiting
Alpheus Medical, Inc.
US Dermatology Partners, Phoenix
NX Development Corp
Hemerion Therapeutics
Dartmouth-Hitchcock Medical Center
Medical College of Wisconsin
Psoriasis Treatment Center of Central New Jersey
Universität Münster
The Center for Clinical and Cosmetic Research
Tel-Aviv Sourasky Medical Center